Literature DB >> 32463459

Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States.

Muthiah Vaduganathan1, Jeroen van Meijgaard2, Mandeep R Mehra1, Jacob Joseph3, Christopher J O'Donnell3, Haider J Warraich3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32463459      PMCID： PMC7256862          DOI： 10.1001/jama.2020.9184

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Internet Searches for Unproven COVID-19 Therapies in the United States.

Authors:  Michael Liu; Theodore L Caputi; Mark Dredze; Aaron S Kesselheim; John W Ayers
Journal:  JAMA Intern Med       Date:  2020-08-01       Impact factor: 21.873

2.  Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.

Authors:  Muthiah Vaduganathan; Orly Vardeny; Thomas Michel; John J V McMurray; Marc A Pfeffer; Scott D Solomon
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

3.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-20       Impact factor: 5.283
  3 in total
  40 in total

1.  Collateral Effects and Mortality of Kidney Transplant Recipients during the COVID-19 Pandemic.

Authors:  Christian Schmidt-Lauber; Christian Günster; Tobias B Huber; Melissa Spoden; Florian Grahammer
Journal:  Kidney360       Date:  2021-11-18

2.  Creation of a State Drug Shortage Dashboard in the COVID-19 Pandemic.

Authors:  Kristin Lux; Melinda Jorns; Carrie Vogler
Journal:  Hosp Pharm       Date:  2021-09-24

3.  Pharmacy Leadership Amid the Pandemic: Maintaining Patient Safety During Uncertain Times.

Authors:  Irene Derrong Lin; John B Hertig
Journal:  Hosp Pharm       Date:  2021-08-05

Review 4.  Behavioral Economics and Ambulatory Antibiotic Stewardship: A Narrative Review.

Authors:  Alexandra R Richards; Jeffrey A Linder
Journal:  Clin Ther       Date:  2021-10-23       Impact factor: 3.637

Review 5.  American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines.

Authors:  Heather M Alger; Christine Rutan; Joseph H Williams; Jason G Walchok; Michele Bolles; Jennifer L Hall; Steven M Bradley; Mitchell S V Elkind; Fatima Rodriguez; Tracy Y Wang; David A Morrow; Sandeep R Das; James A de Lemos
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-06-17

6.  Variation In Telemedicine Use And Outpatient Care During The COVID-19 Pandemic In The United States.

Authors:  Sadiq Y Patel; Ateev Mehrotra; Haiden A Huskamp; Lori Uscher-Pines; Ishani Ganguli; Michael Lawrence Barnett
Journal:  Health Aff (Millwood)       Date:  2021-02       Impact factor: 6.301

7.  Covid Media Misguidance: A Case Report Highlighting the Influence of Media on Patient Medication Decision Making.

Authors:  Shaylee Anderson; Joe Windscheffel; Karen Gunning
Journal:  Innov Pharm       Date:  2021-01-08

8.  Medication safety in a pandemic: A multicentre point prevalence study of QTc monitoring of hydroxychloroquine for COVID-19.

Authors:  Steven M Smoke; Henry Leach; Nicole Leonida; Karan Raja; Monica Shah; Vishal Patel; Gargi Patel; Nicole M Daniel; Jessica Gerges; Akshar Patel
Journal:  J Clin Pharm Ther       Date:  2021-05-06       Impact factor: 2.145

9.  The Impact of Job and Insurance Loss on Prescription Drug use: A Panel Data Approach to Quantifying the Health Consequences of Unemployment During the Covid-19 Pandemic.

Authors:  Amanda Nguyen; Alexandra Guttentag; Diane Li; Jeroen van Meijgaard
Journal:  Int J Health Serv       Date:  2022-02-15       Impact factor: 1.851

10.  Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.

Authors:  Alexandre B Cavalcanti; Fernando G Zampieri; Regis G Rosa; Luciano C P Azevedo; Viviane C Veiga; Alvaro Avezum; Lucas P Damiani; Aline Marcadenti; Letícia Kawano-Dourado; Thiago Lisboa; Debora L M Junqueira; Pedro G M de Barros E Silva; Lucas Tramujas; Erlon O Abreu-Silva; Ligia N Laranjeira; Aline T Soares; Leandro S Echenique; Adriano J Pereira; Flávio G R Freitas; Otávio C E Gebara; Vicente C S Dantas; Remo H M Furtado; Eveline P Milan; Nicole A Golin; Fábio F Cardoso; Israel S Maia; Conrado R Hoffmann Filho; Adrian P M Kormann; Roberto B Amazonas; Monalisa F Bocchi de Oliveira; Ary Serpa-Neto; Maicon Falavigna; Renato D Lopes; Flávia R Machado; Otavio Berwanger
Journal:  N Engl J Med       Date:  2020-07-23       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.